Biotech Company Seeks FDA Approval For Psilocybin-IBS Treatment

High Times
By Thomas EdwardMay 26, 2023, 10:00 am214 pts
Tryp Therapeutics announced on Wednesday that it had “submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its planned Phase 2a clinical trial investigating the effects of psilocybin-assisted psychotherapy in the treatment of patients aged 21+ suffering…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

The best products for Oil Day 2025 68

Delaware: Regulators Announce Adult Use Marijuana Sales to Begin Next Month 64

Medical Cannabis Companies Sue Kentucky Over Licensing Process 56

Gov. Signs Florida Law Allowing Revocation of Medical Cannabis Cards for Drug Crimes 54

House-Approved Veterans Affairs Budget Bill Ends Prohibition on Medical Cannabis Recommendations 53

Canada’s retail cannabis landscape continues to evolve 46

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.